Eye Care
The Pharmacy Times® Eye Care resource center provides clinical news and articles, coverage from ophthalmology conferences and meetings, links to condition-specific resources, and videos and other content.
What can we help you find?
![[[thumbnail_alt_text]]](https://pharmacytimes.s3.amazonaws.com/v1_media/SafeImages/FDA5-644px.jpg)
Brolucizumab is the most clinically advanced humanized single-chain antibody fragment. This type of antibody is highly sought after due to their small size, enhanced tissue penetration, rapid clearance from systemic circulation, and drug delivery characteristics.
![[[thumbnail_alt_text]]](https://pharmacytimes.s3.amazonaws.com/v1_media/SafeImages/Webdam%20Assets/FDA5-644px.jpg)
Alembic Pharmaceuticals has received FDA approval for Dorzolamide Hydrochloride Ophthalmic Solution USP, 2%, therapeutically equivalent to Trusopt Ophthalmic Solution, 2% (Merck Sharp & Dohme Corp.).
![[[thumbnail_alt_text]]](https://pharmacytimes.s3.amazonaws.com/v1_media/SafeImages/Screen%20Shot%202019-07-16%20at%2010_47_14%20AM.png)
Stephanie Conway, PharmD, RPh, Associate Professor at Massachusetts College of Pharmacy & Health Sciences—Worcester/Manchester, discusses best practices for encouraging collaboration between pharmacy and optometry students.
![[[thumbnail_alt_text]]](https://pharmacytimes.s3.amazonaws.com/v1_media/SafeImages/Screen%20Shot%202019-07-16%20at%2010_51_58%20AM.png)
Stephanie Conway, PharmD, RPh, Associate Professor at Massachusetts College of Pharmacy & Health Sciences—Worcester, discusses the links between ophthalmic conditions, over-the-counter ophthalmic products, and pharmacists.
![[[thumbnail_alt_text]]](https://pharmacytimes.s3.amazonaws.com/v1_media/_upload_image/_thumbnails/Screen%20Shot%202019-07-15%20at%2010_07_36%20AM.png)
Kaelen C. Dunican, PharmD, Professor at MCPHS University—Worcester/Manchester, MA discusses an interprofessional, educational activity with pharmacy and optometry students for reviewing common, self-treatable ophthalmic conditions.
![[[thumbnail_alt_text]]](https://pharmacytimes.s3.amazonaws.com/v1_media/SafeImages/Webdam%20Assets/monday%20mystery.jpg)
JK is experiencing gastrointestinal effects. What could be the cause?
![[[thumbnail_alt_text]]](https://pharmacytimes.s3.amazonaws.com/v1_media/SafeImages/PTDecember2017TNeyes.jpg)
Did you know that eyedrops are color-coded for patient safety and adherence?
Vector-based gene therapy shows efficacy treating glaucoma.
![[[thumbnail_alt_text]]](https://pharmacytimes.s3.amazonaws.com/v1_media/SafeImages/AdobeStock_91991055.jpeg)
Daily eye drops may increase medication nonadherence in patients with glaucoma.
![[[thumbnail_alt_text]]](https://ajpblive.s3.amazonaws.com/_media/_image/glaucoma for website.jpg)
Stem cell exosomes observed to protect retinal cells in a recent study.
![[[thumbnail_alt_text]]](https://ajpblive.s3.amazonaws.com/_media/_image/Parkinson's website.jpg)
Observing retinal changes and treating patients with an anti-diabetic drug could protect against Parkinson’s disease progression.
Patients who received their prescriptions by mail were the least likely to be adherent.